Johnson & Johnson has agreed to pay $700 million to settle an investigation by 42 U.S. states and Washington, D.C. into its marketing of baby powder and other talc-based products blamed for allegedly causing cancer.
A state appeals court in New Jersey has tossed out a $223.8 million ruling against Johnson & Johnson regarding its talc powder products, stating that a lower court judge should not have allowed particular scientific testimony to be heard by jurors.
A New Jersey appeals court on Tuesday threw out a $223.8 million verdict against Johnson & Johnson (JNJ.N) that a jury had awarded to four plaintiffs who claimed they developed cancer.
The Johnson & Johnson (J&J) conglomerate is more than quadrupling the amount it had previously set aside to cover its potential liabilities by allocating $8.9 billion to address allegations that their talcum baby powder caused cancer.